English  |  正體中文  |  简体中文  |  總筆數 :2856704  
造訪人次 :  53724978    線上人數 :  884
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"huang c s"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 396-420 / 788 (共32頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-05-26T09:26:54Z High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country Chen I.-C; Wu P.-F; Kuo S.-H; Chen C.-J; Lu Y.-S; Cheng A.-L.; Cheng A.-L.;Lu Y.-S;Chen C.-J;Kuo S.-H;Wu P.-F;Chen I.-C;Chen W.-W;Kuo K.-T;Hsiung C.-N;Chang D.-Y;Kuo W.-H;Chih-Hsin Yang;Huang C.-S;Lee J.-H;Shen C.-Y;Lin C.-H; Lin C.-H; Shen C.-Y; Lee J.-H; Huang C.-S; CHIH-HSIN YANG; Kuo W.-H; Chang D.-Y; Hsiung C.-N; Kuo K.-T; Chen W.-W
臺大學術典藏 2020-05-25T07:35:34Z A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer Chia-Chi Lin; Cheng A.-L; Hsu C.-H; Lu Y.-S; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; Yang C.-H.
臺大學術典藏 2020-05-25T06:52:11Z Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma Cheng A.-L.;Chang K.-J;Chen M.M;Bu C.-F;Yen-Shen Lu;Chao T.-Y;Huang C.-S;Hsu C; Hsu C; Huang C.-S; Chao T.-Y; YEN-SHEN LU; Bu C.-F; Chen M.M; Chang K.-J; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:10Z Recent advances in the management of primary breast cancers Huang C.-S.;Kuo S.-H;Yen-Shen Lu; YEN-SHEN LU; Kuo S.-H; Huang C.-S.
臺大學術典藏 2020-05-25T06:52:09Z Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI Tseng W.-Y.I.;Yen-Shen Lu;Chen J.-H;Liu Y.-J;Huang C.-S;Chang Y.-C; Chang Y.-C; Huang C.-S; Liu Y.-J; Chen J.-H; YEN-SHEN LU; Tseng W.-Y.I.
臺大學術典藏 2020-05-25T06:52:07Z Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms Lien H.-C;Yen-Shen Lu;Cheng A.-L;Chang W.-C;Jeng Y.-M;Kuo Y.-H;Huang C.-S;Chang K.-J;Yao Y.-T.; Lien H.-C; YEN-SHEN LU; Cheng A.-L; Chang W.-C; Jeng Y.-M; Kuo Y.-H; Huang C.-S; Chang K.-J; Yao Y.-T.
臺大學術典藏 2020-05-25T06:52:07Z A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer Lin C.-C;Cheng A.-L;Hsu C.-H;Yen-Shen Lu;Hsu C;Yeh K.-H;Wu C.-Y;Huang C.-S;Yang C.-H.; Lin C.-C; Cheng A.-L; Hsu C.-H; YEN-SHEN LU; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; Yang C.-H.
臺大學術典藏 2020-05-25T06:52:06Z Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients Huang C.-S.;Chen T.-Z;Lin C.-H;Yen-Shen Lu;You S.-L;Lien H.-C;Kuo S.-H; Kuo S.-H; Lien H.-C; You S.-L; YEN-SHEN LU; Lin C.-H; Chen T.-Z; Huang C.-S.
臺大學術典藏 2020-05-25T06:52:05Z The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers Chang K.-J.;Yen-Shen Lu;Lin C.-H;Shen C.-Y;You S.-L;Yang S.-Y;Lien H.-C;Kuo S.-H;Huang C.-S; Huang C.-S; Kuo S.-H; Lien H.-C; Yang S.-Y; You S.-L; Shen C.-Y; Lin C.-H; YEN-SHEN LU; Chang K.-J.
臺大學術典藏 2020-05-25T06:52:04Z Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia Cheng A.-L.;Chang K.-J;Kuo W.-H;Liu J.M;Lan C;Kuo S.-H;Shen Y.-C;Kuo K.-T;Lee W.-C;Huang C.-S;Yen-Shen Lu;Liau J.-Y;Lin C.-H; Lin C.-H; Liau J.-Y; YEN-SHEN LU; Huang C.-S; Lee W.-C; Kuo K.-T; Shen Y.-C; Kuo S.-H; Lan C; Liu J.M; Kuo W.-H; Chang K.-J; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:03Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Cheng A.-L.; Lin C.-H; Chang K.-J; Kuo W.-H; Hsu C; Lee W.-C; Liau J.-Y; Huang C.-S; Shao Y.-Y;Kuo K.-T;Hu F.-C;Yen-Shen Lu;Huang C.-S;Liau J.-Y;Lee W.-C;Hsu C;Kuo W.-H;Chang K.-J;Lin C.-H;Cheng A.-L.; Shao Y.-Y; Kuo K.-T; Hu F.-C; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:52:02Z Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example Huang C.-S;Lin C.-H;Yen-Shen Lu;Shen C.-Y.; Huang C.-S; Lin C.-H; YEN-SHEN LU; Shen C.-Y.
臺大學術典藏 2020-05-25T06:52:00Z Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer Yen-Shen Lu;Chen D.-R;Tseng L.-M;Yeh D.-C;Chen S.-T;Hsieh C.-M;Wang H.-C;Yeh H.-T;Kuo S.-H;Huang C.-S.; YEN-SHEN LU; Chen D.-R; Tseng L.-M; Yeh D.-C; Chen S.-T; Hsieh C.-M; Wang H.-C; Yeh H.-T; Kuo S.-H; Huang C.-S.
臺大學術典藏 2020-05-25T06:51:59Z Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? Lin C.-H;Yen-Shen Lu;Huang C.-S;Kuo K.-T;Wang C.-C;You S.-L;Lin P.-H;Chang D.-Y;Kuo W.-H;Chang K.-J;Cheng A.-L.; Lin C.-H; YEN-SHEN LU; Huang C.-S; Kuo K.-T; Wang C.-C; You S.-L; Lin P.-H; Chang D.-Y; Kuo W.-H; Chang K.-J; Cheng A.-L.
臺大學術典藏 2020-05-25T06:51:58Z The emerging epidemic of estrogen-related cancers in young women in a developing Asian country Cheng A.-L.;You S.-L;Lai M.-S;Cheng W.-F;Huang C.-S;Kuo K.-T;Yen-Shen Lu;Chiang C.-J;Chen Y.-C;Lin C.-H; Lin C.-H; Chen Y.-C; Chiang C.-J; YEN-SHEN LU; Kuo K.-T; Huang C.-S; Cheng W.-F; Lai M.-S; You S.-L; Cheng A.-L.
臺大學術典藏 2020-05-25T06:51:56Z Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance Yao Y.-T.; Lien H.-C;Wang C.-C;Lin C.-H;Yen-Shen Lu;Huang C.-S;Hsiao L.-P;Yao Y.-T.; Lien H.-C; Wang C.-C; Lin C.-H; YEN-SHEN LU; Huang C.-S; Hsiao L.-P
臺大學術典藏 2020-05-25T06:51:56Z Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation Lin C.-H;Liu J.M;Yen-Shen Lu;Lan C;Lee W.-C;Kuo K.-T;Wang C.-C;Chang D.-Y;Huang C.-S;Cheng A.L.; Lin C.-H; Liu J.M; YEN-SHEN LU; Lan C; Lee W.-C; Kuo K.-T; Wang C.-C; Chang D.-Y; Huang C.-S; Cheng A.L.
臺大學術典藏 2020-05-25T06:51:56Z The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines Chen W.-W;Chang D.-Y;Huang S.-M;Lin C.-H;Hsu C;Lin M.-H;Huang C.-S;Yen-Shen Lu;Cheng A.-L.; Chen W.-W; Chang D.-Y; Huang S.-M; Lin C.-H; Hsu C; Lin M.-H; Huang C.-S; YEN-SHEN LU; Cheng A.-L.
臺大學術典藏 2020-05-25T06:51:55Z CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer Kuo S.-H;Yang S.-Y;Lien H.-C;Lo C;Lin C.-H;Yen-Shen Lu;Cheng A.-L;Chang K.-J;Huang C.-S.; Kuo S.-H; Yang S.-Y; Lien H.-C; Lo C; Lin C.-H; YEN-SHEN LU; Cheng A.-L; Chang K.-J; Huang C.-S.
臺大學術典藏 2020-05-25T06:51:55Z Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study Lin C.-H;Chuang P.-Y;Chiang C.-J;Yen-Shen Lu;Cheng A.-L;Kuo W.-H;Huang C.-S;Lai M.-S;You S.-L;Tang C.-H.; Lin C.-H; Chuang P.-Y; Chiang C.-J; YEN-SHEN LU; Cheng A.-L; Kuo W.-H; Huang C.-S; Lai M.-S; You S.-L; Tang C.-H.
臺大學術典藏 2020-05-25T06:51:54Z No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen Chen T.W.-W;Chen H.-M;Lin C.-H;Huang C.-S;Cheng A.-L;Lai M.-S;Yen-Shen Lu; Chen T.W.-W; Chen H.-M; Lin C.-H; Huang C.-S; Cheng A.-L; Lai M.-S; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:51:53Z High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country Lin C.-H;Shen C.-Y;Lee J.-H;Huang C.-S;Yang C.-H;Kuo W.-H;Chang D.-Y;Hsiung C.-N;Kuo K.-T;Chen W.-W;Chen I.-C;Wu P.-F;Kuo S.-H;Chen C.-J;Yen-Shen Lu;Cheng A.-L.; Lin C.-H; Shen C.-Y; Lee J.-H; Huang C.-S; Yang C.-H; Kuo W.-H; Chang D.-Y; Hsiung C.-N; Kuo K.-T; Chen W.-W; Chen I.-C; Wu P.-F; Kuo S.-H; Chen C.-J; YEN-SHEN LU; Cheng A.-L.
臺大學術典藏 2020-05-25T06:51:53Z Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy Shih T.T.-F; Cheng A.-L; Taiwan Breast Cancer Consortium; Huang C.-S; Huang S.-M; Chao T.-C; Chen B.-B; Rau K.-M; Wu P.-F; Tseng L.-M; Yeh D.-C; Lin C.-H; Chen T.W.-W; YEN-SHEN LU; Taiwan Breast Cancer Consortium;Cheng A.-L;Shih T.T.-F;Huang C.-S;Huang S.-M;Chao T.-C;Chen B.-B;Rau K.-M;Wu P.-F;Tseng L.-M;Yeh D.-C;Lin C.-H;Chen T.W.-W;Yen-Shen Lu
臺大學術典藏 2020-05-25T06:51:52Z TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays Lin C.-H;Chen I.-C;Huang C.-S;Hu F.-C;Kuo W.-H;Kuo K.-T;Wang C.-C;Wu P.-F;Chang D.-Y;Wang M.-Y;Chang C.-H;Chen W.-W;Yen-Shen Lu;Cheng A.-L.; Lin C.-H; Chen I.-C; Huang C.-S; Hu F.-C; Kuo W.-H; Kuo K.-T; Wang C.-C; Wu P.-F; Chang D.-Y; Wang M.-Y; Chang C.-H; Chen W.-W; YEN-SHEN LU; Cheng A.-L.
臺大學術典藏 2020-05-25T06:51:52Z Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient Chang Y.-C.;Chen J.-Y;Chen H.-H;Yen-Shen Lu;Huang C.-S;Chang R.-F;Wu L.-A; Wu L.-A; Chang R.-F; Huang C.-S; YEN-SHEN LU; Chen H.-H; Chen J.-Y; Chang Y.-C.

顯示項目 396-420 / 788 (共32頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目